Can You Stay on a Low Dose of Weight Loss Medication After Reaching Your Goal Weight?
After reaching your goal weight, or a lower weight you are trying to maintain, many people ask:
"Can I stay on a lower dose instead of stopping completely?"
For some people, a lower maintenance dose can be reasonable after successful weight loss. It may come up if higher doses are causing side effects, appetite suppression feels too strong, or the ongoing cost is becoming difficult.
Low-dose maintenance is different from changing the dose yourself, splitting doses, stretching injections further apart, or following a micro-dosing plan from social media.
Dose and timing changes should be discussed with the doctor prescribing the treatment, because the options depend on the medicine, device, dose schedule and your health situation.
In simple terms, low-dose maintenance with weight loss medication means continuing prescribed treatment at a lower dose after the main weight-loss phase.
Someone may lose weight on a higher dose, then consider whether a lower dose could help maintain the weight loss they have already achieved.
The aim is to help maintain the weight loss already achieved. A lower dose may be considered to reduce the chance of weight regain while keeping treatment tolerable, affordable and clinically appropriate.
Stopping active treatment is a separate decision.
People sometimes search for a GLP-1 maintenance dose, but there is no single maintenance dose that applies to every GLP-1 or incretin-based medicine. The right plan depends on the medicine, the person, the response to treatment and the reason the dose is being changed.
People often use the terms low dose, micro-dosing and maintenance dose as if they mean the same thing. They do not.
| Term | What it usually means | What to know |
|---|---|---|
| Low-dose maintenance | A lower prescribed dose used after weight loss, with medical review | Supported by emerging evidence in selected situations |
| Micro-dosing | Very small doses below usual treatment ranges, often discussed online | Limited high-quality evidence for long-term weight maintenance |
| Extended-interval dosing | Taking doses less often than the usual schedule, such as every 10 days or every 2 weeks | Limited published evidence and may reduce treatment effect |
With low-dose maintenance, the lower dose is still part of a prescribing plan. Micro-dosing or extending intervals can make the treatment effect less predictable and harder to review if appetite returns, weight increases or side effects occur.
What does the latest evidence say about lower-dose maintenance?
A 2026 Lancet study called SURMOUNT-MAINTAIN looked at people who had already lost weight on weekly injectable treatment.
After the first weight-loss phase, participants were assigned to one of three groups:
- stay on the higher dose they had tolerated during weight loss
- step down to a lower study dose
- switch to placebo, meaning they stopped active medication
People who stayed on the higher dose maintained the most weight loss. People who stepped down to the lower study dose maintained more weight loss than people who switched to placebo.
The lower dose did not preserve weight loss as strongly as staying on the higher dose. Even so, it performed better than stopping active medication.
Because this was one study of one medicine, it does not set the maintenance dose for every person or every treatment. It supports the idea that a prescribed lower dose may provide more support than stopping active treatment altogether.
For more detail on the study results, see long term weight loss medication.
Stopping active treatment means the medicine effect fades. Stepping down means less medicine is used, but some effect may continue.
That can make a difference to appetite, fullness and weight regain. The effect may be weaker than at a higher dose, but it is not the same as having no active treatment.
For more detail on stopping active treatment, see what happens when you stop weight loss injections.
Losing weight and maintaining weight loss are related, but they are not the same job.
During active weight loss, some people need stronger appetite support to reduce intake and establish new routines. After reaching a lower weight, a lower dose may still provide enough support for some people.
A lower dose may help with:
- hunger or cravings returning between meals
- food preoccupation becoming harder to manage
- feeling full with regular meals
- maintaining routines around protein, fibre and physical activity
- reducing the chance of rapid regain after stopping
For other people, reducing the dose may not provide enough support. Hunger may return quickly, weight may start increasing, or health markers such as blood pressure, blood glucose, cholesterol or fatty liver results may need closer control.
A lower dose may be considered at review if:
- weight has been stable for a period of time
- the current dose is causing troublesome nausea, reflux, constipation, diarrhoea or very low appetite
- treatment cost is becoming difficult
- appetite suppression feels stronger than needed
- nutrition, protein intake and physical activity are in a reasonable place
A prescribing doctor would also check whether the medicine has a suitable lower dose, whether the dose schedule allows it, and whether reducing the dose is safe for your health situation.
Reducing the dose may not be suitable if:
- weight regain has already started
- hunger or cravings have increased again between doses
- blood pressure, blood glucose, cholesterol or liver results still need closer management
- there are complex medical issues or medicine interactions
- regular review will be difficult for a while, such as during travel
- pregnancy is planned, suspected or confirmed, or you are breastfeeding
- surgery, endoscopy or another sedated procedure is coming up and the medication plan needs separate advice
Even when a lower dose sounds appealing, a doctor will also weigh the reason treatment was started, current health risks, medicine access and follow-up.
Micro-dosing usually means using doses below standard treatment ranges.
Examples discussed online include:
- staying indefinitely on starter doses
- taking only part of a dose
- using very small amounts to reduce cost
- following non-standard dose schedules suggested by social media or forums
There is much less evidence for true micro-dosing than for prescribed lower-dose maintenance. Feeling well on a very small dose does not prove that it will reliably maintain weight loss or be safe for someone else.
Micro-dosing can also make medical review harder. If weight starts increasing, appetite returns or side effects occur, it may be harder to know whether the issue is the dose, the timing, the medicine, nutrition, another health condition or something else.
Some people stretch the interval between doses to reduce cost or side effects. For example, they may consider taking a weekly injection every 10 days or every 2 weeks.
This is different from taking a prescribed lower dose.
Changing the timing can affect how much medicine is in the body over time. It may lead to appetite returning before the next dose, less predictable side effects, or reduced weight-maintenance support.
There is limited published evidence comparing extended-interval dosing with standard dosing schedules for weight maintenance. If cost or side effects are pushing you toward stretching doses, it is worth raising this directly at review.
Cost is one of the most common reasons people consider reducing dose, stretching doses or stopping treatment.
Before changing dose or timing because of cost, it is worth checking:
- whether a lower dose is clinically suitable
- whether the medicine device and dose schedule allow the proposed dose
- pharmacy price variation
- whether PBS criteria apply to your situation
- how often reviews are needed
- whether nutrition and physical activity support could help with maintenance
For a more detailed breakdown, see weight loss injection costs in Australia.
If a lower-dose plan is agreed, it should include when and how to review it.
Your doctor may review:
- weight trend
- appetite and fullness
- cravings or food preoccupation
- side effects
- blood pressure or blood results
- protein intake and meal pattern
- physical activity and strength work
- cost and pharmacy access
- whether the dose should continue, change or stop
If hunger or cravings increase, weight starts rising, or side effects persist, an earlier review may be needed rather than waiting until the next routine prescription.
During a review, useful questions include:
- Am I ready for maintenance, or am I still in the active weight-loss phase?
- Is there a lower dose that is appropriate for this medicine?
- What would suggest the dose is too low?
- How quickly would we expect appetite or weight to change if the dose is reduced?
- Would a lower dose affect side effects or cost?
- Should any blood tests, blood pressure checks or other reviews be done?
- What should I do if I start regaining weight?
If you want to discuss dose, side effects, cost or long-term treatment, you can book a weight loss review consultation.
Low-dose maintenance may be a reasonable option for some people after successful weight loss, especially when the alternative is stopping active treatment altogether.
Micro-dosing and stretching the time between doses are different. They have less evidence behind them and are not simple substitutes for a prescribed lower-dose plan.
A good maintenance plan looks at weight trend, appetite, side effects, cost, blood results, nutrition, physical activity and follow-up.
Frequently asked questions
Can I stay on a low dose after reaching my goal weight?
Some people may be able to use a lower maintenance dose after losing weight, but it depends on the medicine, response, side effects, health risks, cost and follow-up plan.
Is low-dose maintenance the same as micro-dosing?
No. Low-dose maintenance usually means a lower prescribed dose used with medical review. Micro-dosing usually refers to doses below standard treatment ranges, often with much less evidence.
Can I take my injection every 2 weeks instead of weekly?
Changing the timing should be discussed with the prescribing doctor. Extending the interval may reduce the treatment effect, allow appetite to return, or make side effects less predictable.
Does a lower dose always mean fewer side effects?
Not always. A lower dose may help if symptoms are worse at higher doses, but some symptoms need separate assessment. Persistent nausea, vomiting, reflux, abdominal pain, constipation or diarrhoea should be discussed with a doctor.
Will a lower dose stop weight regain?
It may help some people, but it is not guaranteed. Weight maintenance also depends on nutrition, physical activity, sleep, other health conditions, medicines, stress and follow-up.
What should I do if I regain weight on a lower dose?
A review can check appetite, side effects, dose timing, blood results, nutrition, activity and whether the current plan still suits you.
- Horn DB, Aronne LJ, Wharton S, et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial. The Lancet. Published online May 12, 2026. doi:10.1016/S0140-6736(26)00656-2: https://doi.org/10.1016/S0140-6736(26)00656-2
- American College of Cardiology, SURMOUNT-MAINTAIN: Continuing Tirzepatide Maintains Weight Loss: https://www.acc.org/latest-in-cardiology/journal-scans/2026/05/18/18/10/surmount-maintain
- West S, Scragg J, Aveyard P, et al. Weight regain after cessation of medication for weight management: systematic review and meta-analysis. BMJ. 2026;392.
- Australian Prescriber, Injectable drugs for weight management: https://australianprescriber.tg.org.au/articles/injectable-drugs-for-weight-management.html
- Healthdirect, Weight loss medicine: https://www.healthdirect.gov.au/weight-loss-medicine
- Medical Board of Australia, Telehealth consultations with patients: https://www.medicalboard.gov.au/Codes-Guidelines-Policies/Telehealth-consultations-with-patients.aspx
